Circulating Levels of ELABELA Is Inversely Associated with Hepatic Fibrosis of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

被引：0
作者：
Shi, Min
Cao, Huimin
Liu, Yuting
Gu, Wensha
Zhang, Hong
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1591-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1591-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Liver Fibrosis Is Common in Patients with Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Fatty Liver Disease (NAFLD)
    Lomonaco, Romina
    Fanous, Nada
    Kalavalapalli, Srilaxmi
    Tejera, Lazaro J.
    McCauley, Allison
    Godinez, Eddison
    Mansour, Lydia
    Shrestha, Sulav
    Marte, Jonathan S.
    Fakhry, Jonathan
    Wang, Hannah
    Barb, Diana
    Bril, Fernando
    Cusi, Kenneth
    DIABETES, 2020, 69
  • [22] Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes
    Nabil Noureddin
    Mazen Noureddin
    Amandeep Singh
    Naim Alkhouri
    Digestive Diseases and Sciences, 2022, 67 : 1379 - 1388
  • [23] Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes
    Noureddin, Nabil
    Noureddin, Mazen
    Singh, Amandeep
    Alkhouri, Naim
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (04) : 1379 - 1388
  • [24] Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
    Lee, Chi-Ho
    Seto, Wai-Kay
    Lui, David Tak-Wai
    Fong, Carol Ho-Yi
    Wan, Helen Yilin
    Cheung, Chloe Yu-Yan
    Chow, Wing-Sun
    Woo, Yu-Cho
    Yuen, Man-Fung
    Xu, Aimin
    Lam, Karen Siu-Ling
    DIABETES CARE, 2021, 44 (09) : 2089 - 2097
  • [25] Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
    Mansour, Asieh
    Pourhassan, Saeed
    Gerami, Hadis
    Mohajeri-Tehrani, Mohammad Reza
    Salahshour, Marziye
    Abbasi, Ali
    Madreseh, Elham
    Sajjadi-Jazi, Sayed Mahmoud
    OBESITY SCIENCE & PRACTICE, 2024, 10 (04):
  • [26] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [27] Elevated Serum Cytokeratin-18 Levels in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Lee, Tao-Chun
    DIABETES, 2018, 67
  • [28] High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
    Portillo-Sanchez, Paola
    Bril, Fernando
    Maximos, Maryann
    Lomonaco, Romina
    Biernacki, Diane
    Orsak, Beverly
    Subbarayan, Sreevidya
    Webb, Amy
    Hecht, Joan
    Cusi, Kenneth
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (06) : 2231 - 2238
  • [29] Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    Meroni, Marica
    Longo, Miriam
    Lombardi, Rosa
    Paolini, Erika
    Macchi, Chiara
    Corsini, Alberto
    Sirtori, Cesare R.
    Fracanzani, Anna Ludovica
    Ruscica, Massimiliano
    Dongiovanni, Paola
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (03) : 535 - 549
  • [30] Prevalence of Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Type 1 Diabetes
    Salah, Tareq
    Tomah, Shaheen
    Al-Badri, Marwa
    Kibaa, Karim
    Dhaver, Shilton E.
    Curry, Michael P.
    Lai, Michelle
    Jiang, Zhenghui
    Khater, Abdelrahman
    Mccarragher, Ryan
    Demattos, Lily
    Minh Tran
    Hamdy, Osama
    DIABETES, 2023, 72
12345